首页> 外文期刊>Investigative ophthalmology & visual science >Corneal nerve morphology: a non-invasive surrogate of nerve fibre damage and repair in chemotherapy-associated peripheral neuropathy
【24h】

Corneal nerve morphology: a non-invasive surrogate of nerve fibre damage and repair in chemotherapy-associated peripheral neuropathy

机译:角膜神经形态:与化学疗法相关的周围神经病的神经纤维损伤和修复的非侵入性替代

获取原文
           

摘要

Purpose: Chemotherapy-associated neuropathy is a cause of disability in patients with cancer, for diagnosis invasive techniques such as skin or sural nerve biopsy are used. Corneal confocal microscopy is a noninvasive technique that allows to assess a??in-vivoa?? all structures of the cornea, including the corneal nerves. The purpose of the current study is to determine the ability of this technique to quantify the degeneration and regeneration of corneal nerves in patients with peripheral neuropathy secondary to chemotherapy. Methods: Twelve patients with chemotherapy-associated neuropathy (study group) and 12 healthy volunteers were included. Laser in vivo confocal microscopy (IVCM) of the cornea was performed in one eye of each participant using the Heidelberg Retina Tomograph with the Rostock Cornea module. By a combination of clinical assessment and symptomatic neuropathy score an overall neuropathy score was obtained. Results: Median age was 59 year in the study group and 57.2 years in the control group. The average time between evaluation and completion of chemotherapy was 11,8 month (2-38 months). The severity of the neuropathy was mild in one patient (8.3%), moderate in 8 (66.6%) and severe in 3 patients (25%).The IVCM revealed a reduction in nerve density and number of branching in 7 patients (58.3%) compared with 1 (8.3%) in the control group (p=0.0272). There was not a significant correlation between the sub-basal nerve findings and the severity of the neuropathy and with the time of chemotherapy ending. Conclusions: Correlation between the chemotherapy-associated neuropathy and sub-basal nerve morphology has been found. Given that IVCM is a non invasive and painless technique which allows serial assessment of the sub-basal nerve morphology we suggest that IVCM may be an important tool to assess nerve degeneration and regeneration and therefore become a surrogate marker in the monitoring of chemotherapy associated neuropathy.
机译:目的:化学疗法相关的神经病是癌症患者致残的原因,用于诊断侵入性技术,例如皮肤或腓肠神经活检。角膜共聚焦显微镜是一种非侵入性技术,可以评估“体内”。角膜的所有结构,包括角膜神经。本研究的目的是确定这项技术对化疗继发的周围神经病患者角膜神经变性和再生进行定量的能力。方法:纳入12例化疗相关神经病患者(研究组)和12名健康志愿者。使用带有Rostock Cornea模块的Heidelberg视网膜断层扫描仪,在每位参与者的一只眼睛中进行角膜的激光体内共聚焦显微镜(IVCM)。通过临床评估和症状性神经病变评分的结合,获得了总体神经病变评分。结果:研究组中位年龄为59岁,对照组为57.2岁。从评估到完成化疗的平均时间为11.8个月(2-38个月)。神经病变的严重程度为轻度1例(8.3%),中度8例(66.6%)和重度3例(25%)。IVCM显示7例神经密度降低和分支数减少(58.3%) ),而对照组则为1(8.3%)(p = 0.0272)。基底下神经的发现与神经病变的严重程度以及化疗结束时间之间没有显着相关性。结论:已发现化学疗法相关的神经病与基底下神经形态之间的相关性。鉴于IVCM是一种无创且无痛的技术,可以连续评估基底下神经的形态,因此我们建议IVCM可能是评估神经变性和再生的重要工具,因此成为监测化疗相关神经病变的替代指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号